Provided by Tiger Fintech (Singapore) Pte. Ltd.

Streamex Corp.

5.52
+0.11002.03%
Post-market: 5.550.0299+0.54%19:59 EDT
Volume:856.39K
Turnover:4.49M
Market Cap:194.70M
PE:-7.37
High:5.59
Open:5.46
Low:4.90
Close:5.41
52wk High:14.11
52wk Low:0.2300
Shares:35.27M
Float Shares:27.92M
Volume Ratio:0.66
T/O Rate:3.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7487
EPS(LYR):-0.7487
ROE:--
ROA:-30.45%
PB:-53.83
PE(LYR):-7.37

Loading ...

Company Profile

Company Name:
Streamex Corp.
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
5
Office Location:
2431 Aloma Avenue,Suite 243,Winter Park,Florida,United States
Zip Code:
32792
Fax:
- -
Introduction:
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Directors

Name
Position
Henry McPhie
Chief Executive Officer and Director
Morgan Lekstrom
Chairman of the Board
Christopher A. Baer
Independent Director
Donald F. Browne
Independent Director
Steven E. Abelman
Independent Director
Anthony Amato
Director

Shareholders

Name
Position
Henry McPhie
Chief Executive Officer and Director
Ferdinand Groenewald
Interim Chief Financial Officer